AUS
NZ
UK
CA
USA
IND
Tenet Healthcare (NYSE:THC) leaped 18 places in Barchart’s Top 100 list, now ranked 67th with a weighted alpha of 119.97, surpassing its impressive 106% return over the last year. When the weighted alpha exceeds the 52-week return, it suggests that the stock is experiencing short-term momentum and may continue its upward trajectory. Tenet owns a diverse array of healthcare facilities, including acute care and specialty hospitals, outpatient and emergency facilities, micro-hospitals, and ambulatory surgery centers, all contributing to its robust performance.
Earnings Report and Stock Surge
Tenet Healthcare recently reported its Q2 2024 earnings, which significantly boosted its stock by 10% over four consecutive days of trading. The company posted revenues of $5.1 billion, exceeding Wall Street expectations by $100 million, and adjusted earnings per share of $2.31, surpassing analyst forecasts by 41 cents. These strong financial results, coupled with a new revenue guidance of $20.8 billion and an adjusted EPS expectation of $10.77 for 2024, indicate sustained growth and profitability.
Operational Efficiency and Valuation
Despite its 106% stock rise in the past year, Tenet's valuation remains attractive, trading at 14.2 times its $10.77 EPS estimate. Historically, the company has traded between 16-20 times its normalized EPS, suggesting it is still reasonably priced. Free cash flow yield, a crucial indicator, stands at 4.5%, based on a current enterprise value of $29.32 billion. This yield is within the fair value range of 4% to 8%, highlighting the company's efficient cash generation and solid financial health among healthcare stocks.
Strong Free Cash Flow and Debt Management
Tenet's free cash flow has surged 39% year-over-year to $948 million in the first six months of 2024, with a trailing 12-month free cash flow of $1.76 billion, resulting in a 6.0% yield. The company’s balance sheet shows net debt of $9.99 billion, which is 34% of its enterprise value. Long-term debt management is prudent, with 50% of the $12.87 billion maturing in five years or more. This strategic debt reduction, supported by increasing earnings and free cash flow, fortifies Tenet’s financial stability.
Ambulatory Care and Growth Prospects
Tenet operates two main segments: Ambulatory Care and Hospital Operations and Services. Ambulatory Care, while generating 22% of the second-quarter revenue, accounted for 47% of adjusted EBITDA, showcasing its higher profitability. United Surgical Partners International (USPI), a key component of Tenet’s Ambulatory Care segment, has experienced significant growth since merging with Tenet’s assets in 2015. USPI’s revenue has grown at a compound annual growth rate of 13.3%, with adjusted EBITDA increasing by 14.5%.
Strategic Acquisitions and Long-Term Growth
Tenet’s growth strategy includes acquiring facilities at reasonable multiples (8-10 times EBITDA) and enhancing their profitability. Over the past six-and-a-half years, the company has doubled the number of its operated facilities. This strategic expansion, combined with its strong operational performance and financial health, positions Tenet for sustained long-term growth. The company’s focus on efficiency and profitability in its core segments underscores why its stock is performing well and is expected to continue on this positive trajectory.
